200,000+ products from a single source!
sales@angenechem.com
Home > Sulfanilamide > 25182-53-0
CAS No: 25182-53-0 Catalog No: AG002QSH MDL No:MFCD18805221
Title | Journal |
---|---|
An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides. | Chemical biology & drug design 20101201 |
Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. | Bioorganic & medicinal chemistry letters 20100801 |
Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. | Bioorganic & medicinal chemistry 20090715 |
Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors. | Bioorganic & medicinal chemistry letters 20090615 |
Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII. | Bioorganic & medicinal chemistry letters 20080115 |
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. | Journal of medicinal chemistry 20040226 |
Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents. | Journal of pharmaceutical sciences 20021001 |
Bile acid derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibition effects. | Bioorganic & medicinal chemistry 20020801 |
Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails. | Bioorganic & medicinal chemistry letters 20020617 |
Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. | Journal of medicinal chemistry 20020117 |
© 2019 Angene International Limited. All rights Reserved.